Biopharmaceutical pipelines in Germany 2022, by field of indication

Number of active biopharmaceutical ingredients in development in Germany as of 2022, by field of indication

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

July 2023

Region

Germany

Survey time period

2022

Supplementary notes

Phase l/ lla included in Phase I; active substances in the authorization procedure contained in Phase II; active ingredients in most studies carried out by operating in German companies.
* Biotechnologically and genetically engineered
** U. a. Antianaemic, Antithrimbotika, fibrinolytic etc., exclusive hematological oncology
*** Eye and ear diseases
**** Among other substances for treating muscle, bone, cardiovascular etc. diseases.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Biotechnology in Germany "

Other statistics that may interest you Biotechnology in Germany

Overview

4

Biopharmaceutical market

7

Research and components

7

Funding

3

Occupation

3

Further related statistics

16
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.